After Cancer, Removing a Healthy Breast - New York Times (blog) ( Mon, 08 Mar 2010 22:33:40 GMT+00:00 ) New York Times (blog) After Cancer, Removing a Healthy Breast New York Times (blog) But for most women given a diagnosis of breast cancer, cutting off a healthy breast does not improve the odds of survival. A new study in The Journal of the ... and more » Abraxis BioScience Reports 2009 Fourth Quarter and Full Year Financial Results - Genetic Engineering News (press release) ( Thu, 11 Mar 2010 13:46:57 GMT+00:00 ) Abraxis BioScience Reports 2009 Fourth Quarter and Full Year Financial Results Genetic Engineering News (press release) According to IntrinsiQ data for 2009, in all lines of metastatic breast cancer (MBC), ABRAXANE use represented 32.5 percent of the taxane market. ... and more » BC cancer researchers make lymphoma 'breakthrough' - Canada.com ( Wed, 10 Mar 2010 23:55:07 GMT+00:00 ) BC cancer researchers make lymphoma 'breakthrough' Canada.com In the study, which investigated patient records, the 10-year survival rate in patients with the highest number of the macrophages was 59.6 per cent ... and more » Abraxis BioScience Reports 2009 Fourth Quarter and Full Year Financial Results - dBusinessNews San Jose (press release) ( Thu, 11 Mar 2010 13:35:07 GMT+00:00 ) Abraxis BioScience Reports 2009 Fourth Quarter and Full Year Financial Results dBusinessNews San Jose (press release) According to IntrinsiQ data for 2009, in all lines of metastatic breast cancer (MBC), ABRAXANE use represented 32.5 percent of the taxane market. ... and more » Abraxis BioScience Reports 2009 Fourth Quarter and Full Year Financial Results - dBusinessNews Sacramento (press release) ( Thu, 11 Mar 2010 13:31:15 GMT+00:00 ) Abraxis BioScience Reports 2009 Fourth Quarter and Full Year Financial Results dBusinessNews Sacramento (press release) According to IntrinsiQ data for 2009, in all lines of metastatic breast cancer (MBC), ABRAXANE use represented 32.5 percent of the taxane market. ... and more » Clinical Trial Using Proteomics Technologies for Personalized Medicine ... - GenomeWeb Daily News ( Tue, 09 Mar 2010 22:29:34 GMT+00:00 ) Clinical Trial Using Proteomics Technologies for Personalized Medicine ... GenomeWeb Daily News The study showed that a personalized medicine-based approach using a molecular profile of a patient's cancer could improve the survival rate of cancer ... and more » B.C. cancer researchers make lymphoma 'breakthrough' - Canada.com ( Thu, 11 Mar 2010 15:08:39 GMT+00:00 ) B.C. cancer researchers make lymphoma 'breakthrough' Canada.com In the study, which investigated patient records, the 10-year survival rate in patients with the highest number of the macrophages was 59.6 per cent ... and more » Hodgkin's lymphoma breakthrough puts BC Cancer Agency research on world stage - Global BC ( Thu, 11 Mar 2010 16:38:17 GMT+00:00 ) Global BC Hodgkin's lymphoma breakthrough puts BC Cancer Agency research on world stage Global BC The 10-year survival rate in patients with the highest number of such cells was 59.6 per cent compared to 88.6 per cent in patients with a lower number. ... and more » Freezing breast tumors - Investor's Business Daily ( Wed, 10 Mar 2010 01:25:20 GMT+00:00 ) Freezing breast tumors Investor's Business Daily The researchers said the rapid freezing method was effective in mice, and when the tumors were frozen rapidly in less than 30 seconds, the survival rate of ... and more » Hodgkin's lymphoma breakthrough puts BC Cancer Agency research on world stage - Victoria Times Colonist (blogs) (blog) ( Thu, 11 Mar 2010 14:51:40 GMT+00:00 ) Hodgkin's lymphoma breakthrough puts BC Cancer Agency research on world stage Victoria Times Colonist (blogs) (blog) The 10-year survival rate in patients with the highest number of such cells was 59.6 per cent compared to 88.6 per cent in patients with a lower number. ... and more » Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter ... - Your-Story.org (press release) ( Thu, 11 Mar 2010 12:11:12 GMT+00:00 ) Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter ... Your-Story.org (press release) Peregrine has completed the combination treatment period in its three Phase II bavituximab clinical trials for breast cancer and non-small cell lung cancer ... and more » BC cancer researchers make lymphoma 'breakthrough' - StarPhoenix ( Thu, 11 Mar 2010 15:12:53 GMT+00:00 ) BC cancer researchers make lymphoma 'breakthrough' StarPhoenix In the study, which investigated patient records, the 10-year survival rate in patients with the highest number of the macrophages was 59.6 per cent ... and more » Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter ... - Behavioral Health Central (blog) ( Thu, 11 Mar 2010 16:12:04 GMT+00:00 ) Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter ... Behavioral Health Central (blog) Peregrine has completed the combination treatment period in its three Phase II bavituximab clinical trials for breast cancer and non-small cell lung cancer ... and more » Nektar Announces Positive Phase 2 Clinical Data from First Stage of NKTR-102 ... - PipelineReview.com (press release) ( Mon, 08 Mar 2010 23:40:20 GMT+00:00 ) Nektar Announces Positive Phase 2 Clinical Data from First Stage of NKTR-102 ... PipelineReview.com (press release) The primary endpoint for the study is overall response rate using Gynecologic Cancer InterGroup (GCIG) criteria, a combination of response by tumor imaging ... and more » Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter ... - Trading Markets (press release) ( Thu, 11 Mar 2010 12:19:29 GMT+00:00 ) Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter ... Trading Markets (press release) Peregrine has completed the combination treatment period in its three Phase II bavituximab clinical trials for breast cancer and non-small cell lung cancer ... and more » BC cancer researchers make lymphoma 'breakthrough' - Calgary Herald ( Wed, 10 Mar 2010 23:54:11 GMT+00:00 ) BC cancer researchers make lymphoma 'breakthrough' Calgary Herald In the study, which investigated patient records, the 10-year survival rate in patients with the highest number of the macrophages was 59.6 per cent ... and more » A Bank Loan At | A Bank Loan Is | A Cash Card Online | Advertising On Web Pages | An Online Bank Account With | Are Internet Bank | Attorney For The Defense | Bank Account Online No | Bankruptcy Auction Uk | Bankruptcy Laws Uk | Bankruptcy Sales Uk | Business Bank Accounts For Bad Credit | Business Banking Deposit Account | Calling Services | Cancer Patient | Cash Card A Debit | Cash Card To Debit | Cash From My Credit | Cash Limit Credit | Cash Or Debit Card | Cheapest Business Banking | Commercial Loan To | Commercial Mortgage Backed | Conference Calls Service | Credit Cards And Cash | Credit Reports For Businesses | Data Recovery Softwares | File Recovery Programs | Free Credit Report The | Free Data Recover | Free List Of Business | Health Care | Health | Home Based | Home Loans Commercial | Jobs After Bankruptcy | Lead Defense Attorney | Lists For Business | Loans No Bank | Loans Without A Bank | Media | Mortgages For Commercial | Moving Companies Uk | New York Defense Attorney | Online Only Bank Account | Pearls | Phone Conference Call Service | Solicitor Uk | Status Commercial Mortgages | Unlimited Conference Calling | York Moving Company